Professor Danny Rischin: Cisplatin or cetuximab in HPV-associated oropharyngeal cancer

New data from the TransTasman Radiation Oncology Group, presented by Professor Danny Rischin, Head of the Department of Medical Oncology at Peter Mac has confirmed radiotherapy and cisplatin as standard of care for HPV-associated oropharyngeal cancer. In a poster presentation held at the virtual 2021 ASCO meeting this week Professor Rischin discussed findings from a ...

Already a member?

Login to keep reading.

© 2022 the limbic